Altered first-trimester screening markers after IVF/ICSI: No relationship with small-for-gestational-age and number of embryos transferred

Reproductive BioMedicine Online

Volumn 20, Issue 4, 2010, Pages 516-522

  Bender, F ^a   Hecken, J ^b   Reinsberg, J ^a   Berg, C ^b   Van Der Ven, H ^a   Gembruch, U ^b   Geipel, A ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

First trimester screening; ICSI; IVF; Pregnancy associated plasma protein A (PAPP A); Small for gestational age; human chorionic gonadotrophin ( HCG)

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PROTEIN A;

ADULT; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; PROTEIN BLOOD LEVEL; SCREENING; SMALL FOR DATE INFANT;

EID: 77951652391     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.12.025     Document Type: Article

References (52)

1. Anckaert, E., Schiettecatte, J., Sleurs, E., Devroey, P., Smitz, J., 2008. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil. Steril. 90, 1206-1210.
2. Avent, N.D., Madgett, T.E., Maddocks, D.G., Soothill, P.W., 2009. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications. Curr. Opin. Obstet. Gynecol. 21, 175-179.
3. Bellver, J., Lara, C., Soares, S.R., et al., 2005. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum. Reprod. 20, 2623-2627.
4. Cicero, S., Curcio, P., Papageorghiou, A., Sonek, J., Nicolaides, K., 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358, 1665-1667. (Pubitemid 33124323)
5. De Sutter, P., Bontinck, J., Schutysers, V., et al., 2006. First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction. Hum. Reprod. 21, 1907-1911.
6. Englert, Y., Roger, M., Belaisch-Allart, J., Jondet, M., Frydman, R., Testart, J., 1984. Delayed appearance of plasmatic chorionic gonadotropin in pregnancies after in-vitro fertilization and embryo transfer. Fertil. Steril. 42, 835-838.
7. Frishman, G.N., Canick, J.A., Hogan, J.W., Hackett, R.J., Kellner, L.H., Saller Jr., D.N., 1997. Serum triple-marker screening in in-vitro fertilization and naturally conceived pregnancies. Obstet. Gynecol. 90, 98-101.
8. Gagnon, A., Wilson, R.D., Audibert, F., et al., 2008. Obstetrical complications associated with abnormal maternal serum markers analytes. J. Obstet. Gynecol. Can. 30, 918-949.
9. Geipel, A., Berg, C., Katalinic, A., et al., 2004. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod. Biomed. Online 8, 119-124.
10. Geipel, A., Gembruch, U., Ludwig, M., et al., 1999. Genetic sonography as the preferred option of prenatal diagnosis in patients with pregnancies following intracytoplasmic sperm injection. Hum. Reprod. 14, 2629-2634.
11. Ghisoni, L., Ferrazzi, E., Castagna, C., Levi Setti, P.E., Masini, A.C., Pigni, A., 2003. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 24 (Suppl. B), S99-S103. (Pubitemid 37321802)
12. Gjerris, A.C., Loft, A., Pinborg, A., Christiansen, A., Tabor, A., 2009a. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet. Gynecol. 33, 8-17.
13. Gjerris, A.C., Loft, A., Pinborg, A., Christiansen, M., Tabor, A., 2009b. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology. Hum. Reprod. 24, 55-62.
14. Gjerris, A.C., Loft, A., Pinborg, A., Tabor, A., Christiansen, M., 2008. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length. Ultrasound Obstet. Gynecol. 32, 612-617.
15. Handschuh, K., Guibourdenche, J., Guesnon, M., Laurendeau, I., Evain-Brion, D., Fournier, T., 2006. Modulation of PAPP-A expression by PPARgamma in human first trimester trophoblast. Placenta 27 (Suppl. A), S127-S134.
16. Heinonen, S., Ryynanen, M., Kirkinen, P., Hippelainen, M., Saarikoski, S., 1996. Effect of in-vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil. Steril. 66, 398-403.
17. Heimerhorst, F.M., Perquin, D.A., Donker, D., Keirse, M.J., 2004. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. Br. Med. J. 328, 261-267.
18. Hui, P.W., Lam, Y.H., Tang MH, N.G.E.H., Yeung, W.S., Ho, P.C., 2005. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in-vitro fertilization and intracytoplasmic sperm injection. Prenat. Diagn. 25, 390-393.
19. Kagan, K.O., Valencia, C., Livanos, P., Wright, D., Nicolaides, K.H., 2009. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet. Gynecol. 33, 18-22.
20. Kagan, K.O., Wright, D., Spencer, K., Molina, F.S., Nicolaides, K.H., 2008. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet. Gynecol. 31, 493-502.
21. Krantz, D.A., Hallahan, T.W., Orlandi, F., Buchanan, P., Larsen Jr., J.W., Macri, J.N., 2000. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet. Gynecol. 96, 207-213.
22. Lam, Y.H., Yeung, W.S., Tang, M.H., Ng, E.H., So, W.W., Ho, P.C., 1999. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum. Reprod. 14, 2120-2123.
23. Lambert-Messerlian, G., Dugoff, L., Vidaver, J., et al., 2006. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat. Diagn. 26, 672-678.
24. Liao, A.W., Heath, V., Kametas, N., Spencer, K., Nicolaides, K.H., 2001. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum. Reprod. 16, 1501-1504.
25. Maiz, N., Valencia, C., Emmanuel, E.E., Staboulidou, I., Nicolaides, K.H., 2008. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet. Gynecol. 112, 598-605.
26. Maymon, R., Jauniaux, E., 2002. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod. Biomed. Online 4, 285-293.
27. Maymon, R., Shulman, A., 2001. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum. Reprod. 16, 691-695.
28. Maymon, R., Shulman, A., 2002. Serial first- and second-trimester Down's syndrome screening tests among IVF- versus naturally-conceived singletons. Hum. Reprod. 17, 1081-1085.
29. Maymon, R., Shulman, A., 2004. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat. Diagn. 24, 125-129.
30. Meschede, D., Lemcke, B., Stussel, J., Louwen, F., Horst, J., 1998. Strong preference for non-invasive prenatal diagnosis in women pregnant through intracytoplasmic sperm injection. Prenat. Diagn. 18, 700-705.
31. Niemimaa, M., Heinonen, S., Seppala, M., Hippelainen, M., Martikainen, H., Ryynanen, M., 2001. First-trimester screening for Down's syndrome in in-vitro fertilization pregnancies. Fertil. Steril. 76, 1282-1283.
32. Ong, C.Y., Liao, A.W., Spencer, K., Munim, S., Nicolaides, K.H., 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br. J. Obstet. Gynecol. 107, 1265-1270.
33. Orlandi, F., Rossi, C., Allegra, A., et al., 2002. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat. Diagn. 22, 718-721.
34. Pan, P.D., Peter, I., Lambert-Messerlian, G.M., Canick, J.A., Bianchi, D.W., Johnson, K.L., 2005. Cell-free fetal DNA levels in pregnancies conceived by IVF. Hum. Reprod. 20, 3152-3156.
35. Papageorghiou, A.T., Leslie, K., 2007. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr. Opin. Obstet. Gynecol. 19, 103-109.
36. Perheentupa, A., Ruokonen, A., Tuomivaara, L., Ryynanen, M., Martikainen, H., 2002. Maternal serum beta-HCG and alpha-fetoprotein concentrations in singleton pregnancies following assisted reproduction. Hum. Reprod. 17, 794-797.
37. Phil, K., Larsen, T., Krebs, L., Christiansen, M., 2008. First trimester maternal serum PAPP-A, ß-hCG and ADAM12 in prediction of small-for-gestational-age fetuses. Prenat. Diagn. 28, 1131-1135.
38. Poikkeus, P., Gissler, M., Unkila-Kallio, L., Hyden-Granskog, C., Tiitinen, A., 2007. Obstetric and neonatal outcome after single embryo transfer. Hum. Reprod. 22, 1073-1079.
39. Räty, R., Virtanen, A., Koskinen, P., et al., 2002. Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum. Reprod. 17, 481-484.
40. Reddy, U.M., Wappner, R.J., Reber, R.W., Tasca, R.J., 2007. Infertility, assisted reproductive technology, and adverse pregnancy outcomes. Obstet. Gynecol. 109, 967-977.
41. Schover, L.R., Thomas, A.J., Falcone, T., Attaran, M., Goldberg, J., 1998. Attitudes about genetic risk of couples undergoing in-vitro fertilization. Hum. Reprod. 13, 862-866.
42. Smith, G.C., Stenhouse, EJ., Crossley, J.A., Aitken, D.A., Cameron, A.D., Connor, J.M., 2002. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J. Clin. Endocrinol. Metab. 87, 1762-1767.
43. Spencer, K., Nicolaides, K.H., 2003. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Br. J. Obstet. Gynecol. 110, 276-280.
44. Spencer, K., Souter, V., Tul, N., Snijders, R., Nicolaides, K.H., 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet. Gynecol. 13, 231-237.
45. Spencer, K., Spencer, C.E., Power, M., Dawson, C., Nicolaides, K.H., 2003. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. Br. J. Obstet. Gynecol. 110, 281-286.
46. Tul, N., Novak-Antolic, Z., 2006. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat. Diagn. 26, 1206-1211.
47. Tul, N., Pusenjak, S., Osredkar, J., Spencer, K., Novak-Antolic, Z., 2003. Predicting complications of pregnancy with first-trimester maternal serum free-beta hCG, PAPP-A and inhibin-A. Prenat. Diagn. 23, 990-996.
48. Voigt, M., Schneider, K.T., Jährig, K., 1996. Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body weight of newborn infants. Geburtshilfe Frauenheilkd 56 (10), 550-558.
49. Wald, N.J., White, N., Morris, J.K., Huttly, W.J., Canick, J.A., 1999. Serum markers for Down's syndrome in woman who have had in-vitro fertilisation: implications for antenatal screening. Br. J. Obstet. Gynecol. 106, 1304-1306.
50. Wojdemann, K.R., Larsen, S.O., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A., 2001. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat. Diagn. 21, 563-565.
51. Yaron, Y., Heifetz, S., Ochshorn, Y., Lehavi, O., Orr-Urtreger, A., 2002a. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat. Diagn. 22, 778-782.
52. Yaron, Y., Ochshorn, Y., Heifetz, S., Lehavi, O., Sapir, Y., Orr-Urtreger, A., 2002b. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn. Ther. 17, 352-356.